✦ LIBER ✦

Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma

✍ Scribed by Toni K. Choueiri; Zita Dubauskas Lim; Michelle S. Hirsch; Pheroze Tamboli; Eric Jonasch; David F. McDermott; Paola Dal Cin; Paul Corn; Ulka Vaishampayan; Daniel Y.C. Heng; Nizar M. Tannir

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 315 KB
Volume: 116
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.25512

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vascular endothelial growth factor-targe

Vascular endothelial growth factor-targeted therapy in metastatic renal cell carcinoma

✍ Brian I. Rini 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB 👁 2 views

The impact of kidney function on the out

The impact of kidney function on the outcome of metastatic renal cell carcinoma patients treated with vascular endothelial growth factor-targeted therapy

✍ Robyn Macfarlane; Daniel Y. C. Heng; Wanling Xie; Jennifer J. Knox; David F. McD 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

Clinical factors associated with outcome

Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy

✍ Toni K. Choueiri; Jorge A. Garcia; Paul Elson; Mohamad Khasawneh; Saif Usman; Al 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

## Abstract ## BACKGROUND. Therapy targeted against the vascular endothelial growth factor (VEGF) pathway is a standard of care for patients with metastatic renal cell carcinoma (RCC). The identification of patients who are more likely to benefit from these agents is warranted. ## METHODS. In to